Literature DB >> 34422598

Total thyroidectomy vs. lobectomy in differentiated thyroid cancer: is there a reasonable size cut-off for decision? A narrative review.

Daniele Barbaro1, Giancarlo Basili2, Gabriele Materazzi3.   

Abstract

OBJECTIVE: To analyze all the most recent guidelines/consensus as well as papers regarding the relationship between size of tumor, type of surgery, and prognosis, and to try to produce a critical synthesis for real practice.
BACKGROUND: Differentiated thyroid cancer (DTC) is characterized by a wide range of biological behavior. The type of intervention can range from lobectomy (LT) to total thyroidectomy (TT), with tumor size being a point of discussion in choosing the treatment.
METHODS: We carried out a search on PubMed, EMBASE, and Cochrane Library, looking at all the guidelines and consensus regarding DTC, as well as examining original articles, inserting as our research keys "total thyroidectomy vs. lobectomy in differentiated thyroid cancer" and "hemithyroidectomy in thyroid cancer". The guidelines and consensus published over the last 5 years were 6 in total: ATA Guidelines, Italian Consensus of Six Italian Societies, United Kingdom National Multidisciplinary Guidelines, ESMO Clinical Practice Guidelines, a Practical Guidance of a Multidisciplinary Panel of Experts, and The Revised Clinical Practise Guidelines on the Management of Thyroid Tumours by the Japanese Association of Endocrine Surgeons. There were 13 papers cited in the guidelines, and we found another 5 original articles, all of which were retrospective studies.
CONCLUSIONS: The type of initial surgical intervention must of course consider tumor size, but must also take into account all the risk factors, which is paramount in deciding the type of treatment. LT can have some advantages, and can represent an option that can be offered to patients. However, even in the absence of any special risk factors, a review of the literature suggests to us that patients should be informed that LT for tumors of a size between 2 and 4 cm can be associated with an increased risk of LR as well as with a possible reduced OS. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Total thyroidectomy (TT); differentiated thyroid cancer (DTC); thyroid lobectomy

Year:  2021        PMID: 34422598      PMCID: PMC8340330          DOI: 10.21037/gs-21-242

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  38 in total

1.  Surgery for papillary thyroid carcinoma: is lobectomy enough?

Authors:  Abie H Mendelsohn; David A Elashoff; Elliot Abemayor; Maie A St John
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-11

2.  Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?

Authors:  I D Hay; C S Grant; E J Bergstralh; G B Thompson; J A van Heerden; J R Goellner
Journal:  Surgery       Date:  1998-12       Impact factor: 3.982

3.  Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland.

Authors:  Henryk Zulewski; Luca Giovanella; Stefan Bilz; Emanuel Christ; Andreas Haldemann; Hans Steinert; Sabine Weidner; Daniel Oertli; Frédéric Triponez; Thomas Clerici; Anna Minder; Matthias Dettmer; Paul Komminoth
Journal:  Swiss Med Wkly       Date:  2019-01-27       Impact factor: 2.193

4.  Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  F Pacini; M G Castagna; L Brilli; G Pentheroudakis
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

5.  Low-risk differentiated thyroid cancer: the need for selective treatment.

Authors:  A R Shaha; J P Shah; T R Loree
Journal:  Ann Surg Oncol       Date:  1997-06       Impact factor: 5.344

Review 6.  Thyroid surgery for differentiated thyroid cancer - recent advances and future directions.

Authors:  Tracy S Wang; Julie Ann Sosa
Journal:  Nat Rev Endocrinol       Date:  2018-11       Impact factor: 43.330

7.  Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers.

Authors:  Samer R Rajjoub; Huan Yan; Natalie A Calcatera; Kristine Kuchta; Chi-Hsiung E Wang; Waseem Lutfi; Tricia A Moo-Young; David J Winchester; Richard A Prinz
Journal:  Surgery       Date:  2018-02-13       Impact factor: 3.982

Review 8.  Contemporary Debates in Adult Papillary Thyroid Cancer Management.

Authors:  Donald S A McLeod; Ling Zhang; Cosimo Durante; David S Cooper
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

9.  The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer.

Authors:  Yasuhiro Ito; Naoyoshi Onoda; Takahiro Okamoto
Journal:  Endocr J       Date:  2020-04-09       Impact factor: 2.349

10.  Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  A L Mitchell; A Gandhi; D Scott-Coombes; P Perros
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

View more
  1 in total

1.  Comparison between total thyroidectomy and hemithyroidectomy in TIR3B thyroid nodules management.

Authors:  Domenico Albano; Giorgio Treglia; Francesco Dondi; Raffaele Giubbini; Alessandro Galani; Carlo Cappelli; Francesco Bertagna; Claudio Casella
Journal:  Endocrine       Date:  2022-08-20       Impact factor: 3.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.